Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Enters into $2.5B Credit Facility

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher has entered into a $2.5 billion unsecured, multiyear revolving credit facility, changed the terms of another credit facility, and terminated two credit facilities, it disclosed after the close of the market on Tuesday.

In a document filed with the US Securities and Exchange Commission, Danaher said that on July 15 it entered into a $2.5 billion credit facility with Bank of America as the administrative agent; Swing Line Lender and Citibank as syndication agent; and the Bank of Tokyo-Mitsubishi, JP Morgan Chase Bank, and Wells Fargo Bank as documentation agents.

The credit agreement expires on July 15, 2016. As a result of the new credit facility, Danaher terminated its existing $1.5 billion unsecured multiyear revolving credit facility which was set to expire on April 25, 2012.

The Washington-based conglomerate also said that it reduced the commitments on a $3 billion, 364-day unsecured revolving credit facility that it entered into last month in connection with its $6.8 billion acquisition of Beckman Coulter. As of June 27, Danaher reduced the commitments under the credit facility to $2.2 billion, and on July 15, it further reduced the commitments to $1.5 billion, the company said in its SEC document.

Simultaneous with the new credit facility agreement, Danaher also terminated an existing credit agreement dated April 25, 2006, for a $1.5 billion unsecured, multiyear revolving credit facility. Danaher said that there were no outstanding borrowings under the credit facility at the time of its termination.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.